US Patents in Skin Care Formulation Granted in 2013
LIST OF US PATENTS IN SKIN CARE GRANTED IN 2013
This list includes patents granted in the United States. The list was retrieved by using a refined search strategy on the claims section of all patent applications. Salient search terms included
formulations and compositions in skin, lip and eye care including creams, lotions, toners, pomades, antiwrinkle and antiaging products, nutraceuticals as well as ingredients derived from
nature, biotechnology and nanotechnology to deliver emolliency, humectancy, distinct sensory properties, antioxidant and free radicals protection, etc.

Thank you for visiting FormulaScan . Please click on the Patent No to study the full patent document

US PATENTS IN SKIN CARE FORMULATION PUBLISHED IN 2013



Patent No.: US8343467B2  Issued: 01/Jan/2013

Title: GLYCOPYRROLATE IN COSMETIC PREPARATIONS

Applicant/Assignee: BEIERSDORF AG

Application No.: 11/722992   Filing Date: 27/Dec/2005

Abstract:

Glycopyrronium bromide, derivatives and/or isomers thereof in combination with one or more active substances selected from a list of substances as recited in the claims and/or in the form of a W/Si emulsion, an O/W gel, a soap gel stick, and/or a surfactant-containing cleansing formula, and corresponding cosmetic preparations, in particular deodorant/antiperspirant preparations.

Priority: DE20041063726 Applic. Date: 2004-12-27; DE20041063728 Applic. Date: 2004-12-27; DE20051029385 Applic. Date: 2005-06-23; DE20051029386 Applic. Date: 2005-06-23; DE20051029387 Applic. Date: 2005-06-23; DE20051029388 Applic. Date: 2005-06-23; DE20051029389 Applic. Date: 2005-06-23; DE20051029390 Applic. Date: 2005-06-23; WO2005EP57186 Applic. Date: 2005-12-27

Inventor: WOEHRMANN MICHAEL [DE]; TERSTEGEN LARA [DE]; BIEL STEFAN [DE]; RASCHKE THOMAS [DE]; CERV SVENJA-KATHRIN [DE]; ZILZ WERNER [DE]; UNTIEDT SVEN [DE]; NUEBEL THOMAS [DE]; SCHOENROCK UWE [DE]; MAX HEINER [DE]; BIERGIESSER HELGA [DE]; ECKHARD YVONNE [DE]; MIERTSCH HEIKE [DE]; FOELSTER HEIKE [DE]; MEIER-ZIMMERER CORNELIA [DE]; TRAUPE BERND [DE]; KRUSE INGE [DE]


Patent No.: US8343942B2  Issued: 01/Jan/2013

Title: Methods for treating interstitial cystitis

Applicant/Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION

Application No.: 13/069860   Filing Date: 23/Mar/2011

Abstract:

Described herein are methods for treating interstitial cystitis in a subject comprising administering to the subject an effective amount of a compound which is a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with an unsubstituted alkyl group or fluoroalkyl group.

Priority: US2010-870774 Applic. Date: 2010-08-27; WO2009US39498 Applic. Date: 2009-04-03; US2008-042310P Applic. Date: 2008-04-04; US2010-352550P Applic. Date: 2010-06-08

Inventor: OOTTAMASATHIEN SIAM [US]; JIA WANJIAN [US]; PRESTWICH GLENN D [US]; MCCOARD LINDSI [US]


Patent No.: US8349882B2  Issued: 08/Jan/2013

Title: PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE

Applicant/Assignee: NIHON NOHYAKU CO., LTD, POLA PHARMA INC

Application No.: 12/281967   Filing Date: 02/Oct/2006

Abstract:

A pharmaceutical composition for external use, including: i) luliconazole represented by the following structural formula (1) and/or a salt thereof

and ii) one or two or more selected from N-methyl-2-pyrrolidone, propylene carbonate, and crotamiton.

Priority: JP20060062079 Applic. Date: 2006-03-08; JP20060215871 Applic. Date: 2006-08-08; WO2006JP319708 Applic. Date: 2006-10-02

Inventor: KOBAYASHI HIROKAZU [JP]; NOZAWA AKIRA [JP]; ARIYOSHI KATSUMASA [JP]


Patent No.: US8353399B2  Issued: 15/Jan/2013

Title: Preparation-At-Use Device Comprising Pre-Formed Hydrogel Product

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 13/282568   Filing Date: 27/Oct/2011

Abstract:

Disclosed is a preparation-at-use device comprising: (1) a pre-formed hydrogel component packaged in a first compartment

the pre-formed hydrogel component comprising a gelling agent and a solvent

and (2) a benefit component packaged in a second compartment

the benefit component comprising at least one compound that is unstable when contacted with the pre-formed hydrogel component

wherein the first and second compartments are separately packaged prior to use, and wherein the device comprises means for contacting the pre-formed hydrogel component and benefit component upon use.

Priority: US2010-944047 Applic. Date: 2010-11-11; US2004-864564 Applic. Date: 2004-06-09; US2003-477546P Applic. Date: 2003-06-11

Inventor: UEDA AKIHIRO [JP]; MASUDA KOISHIRO [JP]; TAMIYA KIMIO [JP]; KAJIMOTO HARUHIKO [JP]; ISHIMOTO MASAHIKO [JP]


Patent No.: US8357392B2  Issued: 22/Jan/2013

Title: Dry antiseptic wipes comprising an amphoteric surfactant

Applicant/Assignee:

Application No.: 13/297343   Filing Date: 16/Nov/2011

Abstract:

A personal skin cleansing wipe comprising a flexible substantially dry matrix formed from synthetic, woven, non-woven or knitted fibers impregnated with a substantially anhydrous antimicrobial, antiseptic, antifungal solution in an amount wherein the matrix retains its substantially dry characteristics and the treatment solution includes an amount of PVP-iodine as active in solution in glycol and or glycerin. The treatment solution, in addition to an effective amount of PVP-iodine as active, contains surfactants, preferably Tego TM Betaine CK D, and optionally a compatible fragrance and/or moisturizer. The wipe is activated with water just prior to use.

Priority: US2010-803495 Applic. Date: 2010-06-30; US2009-589820 Applic. Date: 2009-10-30; US2005-118197 Applic. Date: 2005-05-02

Inventor: KELLY ALBERT R [US]; SAFERTEIN LOWELL [US]


Patent No.: US8377455B2  Issued: 19/Feb/2013

Title: BIOSURFACTANT COMPOSITION PRODUCED BY A NEW BACILLUS LICHENIFORMS STRAIN, USES AND PRODUCTS THEREOF

Applicant/Assignee: PAN-ECO S.A, UNIVERSITY TECHNOLOGIES INTERNATIONAL LP

Application No.: 13/131420   Filing Date: 25/Nov/2009

Abstract:

New Bacillus licheniformis strain named V9T14 that produces a new biosurfactant composition that is effective against colonization and/or bio film formation from bacteria. The new biosurfactant composition can be used in combination with biocides for preventing formation and/or for eradicating bacteria grown planktonically and/or as a biofilm, preferably on biotic and/or abiotic surfaces.

Priority: WO2008IB03583 Applic. Date: 2008-12-10; WO2009IB55334 Applic. Date: 2009-11-25

Inventor: CERI HOWARD [CA]; TURNER RAYMOND J [CA]; MARTINOTTI MARIA GIOVANNA [IT]; RIVARDO FABRIZIO [IT]; ALLEGRONE GIANNA [IT]


Patent No.: US8377679B2  Issued: 19/Feb/2013

Title: Use of probiotic lactic acid bacteria for balancing the skin's immune system

Applicant/Assignee: NESTEC S.A

Application No.: 12/454722   Filing Date: 07/Aug/2009

Abstract:

The present invention pertains to the use of probiotics for the preparation of a carrier for balancing the skin's immune function. In particular, the present invention pertains to the use of probiotic micro-organisms for balancing the skin's immune function under stress conditions, such as a exposure to ultraviolet radiation, specifically for enhancing the skin's immune activity and reducing the tendency to develop allergic reactions under such conditions.

Priority: EP20000121865 Applic. Date: 2000-10-06; US2003-381911 Applic. Date: 2003-08-12; WO2001EP11475 Applic. Date: 2001-10-04

Inventor: BAUR MARKUS [DE]; BRETON LIONEL [FR]; COUZY FRANCOIS [CH]; GUENICHE AUDREY [FR]


Patent No.: US8388992B2  Issued: 05/Mar/2013

Title: Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay

Applicant/Assignee: GEORGIA-PACIFIC CONSUMER PRODUCTS LP

Application No.: 11/728407   Filing Date: 26/Mar/2007

Abstract:

A disposable paper towel with an anti-microbial lotion and is provided with a chromatic transfer indicator which undergoes a delayed, visually perceptible color change at a predetermined time after the towel is wetted. An anti-microbial lotion on the towel increases water absorbency times (WAR) to further promote lotion transfer to the skin and increase lotion transfer effectiveness.

Priority: US2006-786819P Applic. Date: 2006-03-28

Inventor: LUU PHUONG VAN [US]; AWOFESO ANTHONY O [US]; YARDLEY CRAIG D [US]; YEH KANG CHANG [US]; JANDA BRUCE W [US]


Patent No.: US8398997B2  Issued: 19/Mar/2013

Title: Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins

Applicant/Assignee: REVANCE THERAPEUTICS, INC

Application No.: 10/591732   Filing Date: 03/Mar/2005

Abstract:

A composition for topical application of a botulinum toxin (including botulinum toxin derivatives) comprises a botulinum toxin and a carrier comprising a polymeric backbone comprising a long-chain polypeptide or nonpeptidyl polymer having attached positively charged branching or efficiency groups. The invention also relates to methods for reducing muscle paralysis and other conditions that may be treated with a botulinum toxin, particularly paralysis of subcutaneous, and most particularly, facial, muscles, by topically applying an effective amount of the botulinum toxin and carrier, in conjunction, to the subject's skin or epithelium. Kits for administration are also described.

Priority: US2004-550015P Applic. Date: 2004-03-03; WO2005US07524 Applic. Date: 2005-03-03

Inventor: DAKE MICHAEL D [US]; WAUGH JACOB M [US]


Patent No.: US8409593B2  Issued: 02/Apr/2013

Title: Methods for reducing tackiness associated with a xanthine compound

Applicant/Assignee: L'OREAL

Application No.: 12/135643   Filing Date: 09/Jun/2008

Abstract:

The invention relates to a composition containing, preferably in a physiologically acceptable medium, at least one xanthine base or a plant extract containing it, at least one polyurethane powder, and at least one non-ionic dimethicone copolyol. The invention also relates to a cosmetic method for combating cellulite and/or orange-peel skin and/or slimming the figure, comprising the application of the composition to the skin. The composition applied to the skin exhibits good cosmetic properties of softness and of non-tackiness.

Priority: FR20040053051 Applic. Date: 2004-12-17; US2005-305293 Applic. Date: 2005-12-19; US2005-640239P Applic. Date: 2005-01-03

Inventor: FONOLLA MORENO ANGELES [FR]; PIOT BERTRAND [FR]


Patent No.: US8409596B2  Issued: 02/Apr/2013

Title: DEODORANT COMPOSITIONS

Applicant/Assignee: E. I. DU PONT DE NEMOURS AND COMPANY, E I DU PONT DE NEMOURS AND COMPANY

Application No.: 13/344237   Filing Date: 05/Jan/2012

Abstract:

This invention relates to deodorant compositions containing polytrimethylene ether glycol homo- and copolymers and/or polytrimethylene glycol ester(s) in a variety of physical forms. In at least one embodiment, the polytrimethylene ether glycol homo- and copolymers and/or polytrimethylene glycol ester(s) can be made from monomers (e.g., 1,3-propanediol) obtained from renewable resources, and can thus be more environmentally friendly than conventional deodorant compositions in terms of manufacture, use and disposal.

Priority: US2007-869056 Applic. Date: 2007-10-09

Inventor: SUNKARA HARI BABU [US]; POLADI RAJA HARI [US]


Patent No.: US8410079B2  Issued: 02/Apr/2013

Title: Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion

Applicant/Assignee: ISLAND KINETICS INC, ISLAND KINETICS

Application No.: 13/226661   Filing Date: 07/Sep/2011

Abstract:

The present invention discloses certain chirally correct polyene cyclodextrin acetals and hemiacetals (formula I) that are effective in providing skin clarification, which is useful for the treatment of acne, and skin disfigurements and skin darkening resulting from acne

skin darkening from cancer, diabetes, radiation treatments, chemotherapy, and sun-burn

mitochondrial and DNA dysfunction

age spots

loss of cellular antioxidants

skin changes associated with aging including collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles and fine lines, oxidation, damage from radiation, damage from free radicals, and damage from UV

dry skin

xerosis

ichthyosis

dandruff

brownish spots

keratoses

melasma

lentigines

liver spots

skin pigmentation including pigmented spots, dark circles under the eyes, darkened skin, and blemishes

oily skin

warts

eczema

pruritic skin

psoriasis

inflammatory dermatoses

topical inflammation

disturbed keratinization

scalp dryness, and combinations thereof

Priority: US2010-851637 Applic. Date: 2010-08-06

Inventor: PETER DAVID WAYNE [US]; STANEK JOHN DILLON [US]; OROZCO CHERIA L [US]; GUPTA SHYAM K [US]


Patent No.: US8414871B2  Issued: 09/Apr/2013

Title: CONTROLLED RELEASES OF ACTIVES IN SKIN

Applicant/Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY

Application No.: 12/525529   Filing Date: 31/Jan/2008

Abstract:

Topical compositions are provided in which active compounds for topical delivery through the stratum corneum are complexed with nanospheres of a triblock copolymer having an A-B-A structure wherein each A end block is a water-soluble, hydrophilic and non-toxic polymer or oligomer

and the hydrophobic middle B block is a hydrophobic polymer or oligomer with the same or different repeating units having the structure according to formula:(I) wherein X is -C-R-C- or -C-

Z is between 2 and about 100, inclusive

R1 is CH-CH or (CH2), wherein n is from 0 to 18, inclusive

R2 is selected from hydrogen and straight and branched alkyl, alkoxy, alkylaryl and alkoxyaryl groups containing up to 18 carbon atoms

and R is selected from a bond or straight and branched alkyl, alkoxy, alkylaryl and alkoxyaryl groups containing up to 18 carbon atoms.

Priority: US2005-191181 Applic. Date: 2005-07-27; US2005-514215 Applic. Date: 2005-11-07; WO2003US15600 Applic. Date: 2003-05-15; US2007-887553P Applic. Date: 2007-01-31; US2002-378042P Applic. Date: 2002-05-15; WO2008US52728 Applic. Date: 2008-01-31

Inventor: KOHN JOACHIM [US]; MICHNIAK BOZENA [US]; DEVORE DAVID [US]; SHEIHET LARISA [US]; CHANDRA PRAFULLA [US]; BATHEJA PRIYA [US]


Patent No.: US8420126B2  Issued: 16/Apr/2013

Title: Amniotic Membrane Preparations and Purified Compositions and Anti-Angiogenesis Treatment

Applicant/Assignee: BIO-TISSUE, INC, TISSUE TECH, INC

Application No.: 13/453840   Filing Date: 23/Apr/2012

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF [beta] signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

Priority: US2006-535924 Applic. Date: 2006-09-27; US2005-720760P Applic. Date: 2005-09-27

Inventor: TSENG SCHEFFER [US]; HE HUA [US]; LI WEI [CN]


Patent No.: US8426466B2  Issued: 23/Apr/2013

Title: Compositions and methods for enhancing active agent absorption

Applicant/Assignee: NEXUS PHARMA, INC

Application No.: 11/805202   Filing Date: 21/May/2007

Abstract:

Compositions and methods for enhancing the absorption of active agents across the mucosa of animal subjects are provided. Methods of administration and appropriate dosage forms are also provided.

Priority: US2006-747900P Applic. Date: 2006-05-22

Inventor: SHIH CHUNG [US]


Patent No.: US8435502B2  Issued: 07/May/2013

Title: COSMETIC/DERMATOLOGICAL COMPOSITIONS COMPRISING NAPHTHOIC ACID COMPOUNDS AND POLYURETHANE POLYMERS

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT

Application No.: 13/171872   Filing Date: 29/Jun/2011

Abstract:

Cosmetic/dermatological compositions for topical application and useful for the treatment, e.g., of acne, contain, formulated into a physiologically acceptable medium, at least one naphthoic acid compound and at least one polyurethane polymer or derivative thereof, the at least one naphthoic acid compound being dispersed therein.

Priority: FR20050009493 Applic. Date: 2005-09-16; US2008-076169 Applic. Date: 2008-03-14; WO2006IB03852 Applic. Date: 2006-09-15; US2005-725279P Applic. Date: 2005-10-12

Inventor: MALLARD CLAIRE [FR]; FERRARA EVE [FR]


Patent No.: US8440210B2  Issued: 14/May/2013

Title: STABILIZED PHARMACEUTICAL PRODUCT

Applicant/Assignee: NYCOMED GMBH, TAKEDA GMBH

Application No.: 13/437569   Filing Date: 02/Apr/2012

Abstract:

Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar.

Priority: GB20030012148 Applic. Date: 2003-05-28; US201113219046 Applic. Date: 2011-08-26; US2010-771557 Applic. Date: 2010-04-30; US2005-259495 Applic. Date: 2005-10-26; WO2004GB02249 Applic. Date: 2004-05-27

Inventor: HEATON ZOE [GB]; GOODWIN DAVID [GB]; BREAKWELL IAIN [GB]


Patent No.: US8440235B2  Issued: 14/May/2013

Title: Amniotic Membrane Preparations and Purified Compositions and Therapy for Scar Reversal and Inhibition

Applicant/Assignee: TISSUETECH, INC

Application No.: 13/453765   Filing Date: 23/Apr/2012

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF beta signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

Priority: US2006-528980 Applic. Date: 2006-09-27; US2005-720760P Applic. Date: 2005-09-27

Inventor: TSENG SCHEFFER [US]; HE HUA [US]; LI WEI [CN]


Patent No.: US8449895B1  Issued: 28/May/2013

Title: Conditioning cleansing cream

Applicant/Assignee:

Application No.: 13/135168   Filing Date: 28/Jun/2011

Abstract:

A conditioning cleansing cream for removing oil and debris from the hair while leaving it soft, detangled, and conditioned is provided. The conditioning cleansing cream comprises an amount of African Black Soap, an amount of Castor Oil, an amount of Aloe Vera Extract, an amount of Jojoba Oil, an amount of Coconut Oil, an amount of Rosemary extract, an amount of Shea Butter, and an amount of Glycerin.

Priority:

Inventor: KOITEH ZAHRAA [US]


Patent No.: US8454945B2  Issued: 04/Jun/2013

Title: TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY

Applicant/Assignee: PATHFINDER MANAGEMENT, INC, BERG PHARMA LLC

Application No.: 12/052825   Filing Date: 21/Mar/2008

Abstract:

The present disclosure provides compositions suitable for delivering lipophilic bioactive agents. The compositions may be utilized to treat numerous diseases and conditions that would benefit from the application of a lipophilic bioactive agent.

Priority: US2007-919554P Applic. Date: 2007-03-22

Inventor: MCCOOK JOHN PATRICK [US]; PERSAUD INDUSHEKHAR [US]; NARAIN NIVEN RAJIN [US]


Patent No.: US8455004B2  Issued: 04/Jun/2013

Title: PRIMARY COMPOSITION COMPRISING A LIPOPHILIC BIOACTIVE COMPOUND

Applicant/Assignee: NESTEC S.A

Application No.: 12/353730   Filing Date: 14/Jan/2009

Abstract:

The invention relates to a primary composition in which at least one lipophilic bioactive compound is mixed with a whey protein, present in an amount effective to increase the bioavailability of the lipophilic bioactive compound. The invention also relates to an oral composition that contains the primary composition in a foodstuff, in a food supplement, or in a pharmaceutical preparation, and to a cosmetic preparation that contains the primary composition. Methods for increasing the bioavailability of the lipophilic bioactive compound and providing increased photostability and oxidation resistance are also provided.

Priority: EP20000111542 Applic. Date: 2000-05-30; US2004-004409 Applic. Date: 2004-12-03; US2002-057660 Applic. Date: 2002-01-25; WO2001EP06145 Applic. Date: 2001-05-29

Inventor: BORTLIK KARLHEINZ [CH]; SAUCY FRANCOISE [CH]; DURUZ ELIANE [CH]; RICHELLE MYRIAM [CH]; LAMBELET PIERRE [CH]; BAUR MARKUS [DE]; PFEIFER ANDREA [CH]


Patent No.: US8455009B2  Issued: 04/Jun/2013

Title: Amniotic Membrane Preparations and Purified Compositions and Anti-Inflammation Methods

Applicant/Assignee: BIO-TISSUE, INC, TISSUETECH, INC

Application No.: 13/453771   Filing Date: 23/Apr/2012

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF beta signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

Priority: US2006-529658 Applic. Date: 2006-09-27; US2005-720760P Applic. Date: 2005-09-27

Inventor: TSENG SCHEFFER [US]; HE HUA [US]; LI WEI [CN]


Patent No.: US8455459B2  Issued: 04/Jun/2013

Title: METHOD OF APPLYING AN INJECTABLE FILLER

Applicant/Assignee: MEDICIS PHARMACEUTICAL CORPORATION

Application No.: 12/184966   Filing Date: 01/Aug/2008

Abstract:

Methods for applying injectable fillers are provided. In some embodiments, the methods can extend effectiveness of the injectable filler. In some embodiments, the methods can provide for an elevated level of effectiveness of the injectable filler. In some embodiments, the methods can prolong the effectiveness of the injectable filler.

Priority: US2007-953661P Applic. Date: 2007-08-02

Inventor: WORTZMAN MITCHELL S [US]; NARINS RHODA [US]; LIN XIAOMING [US]


Patent No.: US8460714B2  Issued: 11/Jun/2013

Title: PURIFIED AMNIOTIC MEMBRANE COMPOSITIONS AND METHODS OF USE

Applicant/Assignee: TISSUE TECH, INC, TISSUETECH, INC

Application No.: 13/438759   Filing Date: 03/Apr/2012

Abstract:

Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF beta signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.

Priority: US2006-528980 Applic. Date: 2006-09-27; US2005-720760P Applic. Date: 2005-09-27

Inventor: TSENG SCHEFFER [US]; HE HUA [US]; LI WEI [CN]


Patent No.: US8461090B2  Issued: 11/Jun/2013

Title: PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 12/633257   Filing Date: 08/Dec/2009

Abstract:

The present invention relates to a dissolvable article in the form of a porous dissolvable solid structure, comprising from about 23% to about 75% surfactant

wherein the surfactant has an average ethoxylate/alkyl ratio of from about 0.001 to about 0.45

from about 10% to about 50% water soluble polymer

and from about 1% to about 15% plasticizer

and wherein the article has a density of from about 0.05 g/cm3 to about 0.25 g/cm3.

Priority: US2008-120643P Applic. Date: 2008-12-08

Inventor: GLENN JR ROBERT WAYNE [US]; HEINRICH JAMES MERLE [US]; KAUFMAN KATHLEEN MARY [US]; RUSCHE JOHN ROBERT [US]; KITKO DAVID JOHNATHAN [US]


Patent No.: US8461091B2  Issued: 11/Jun/2013

Title: PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 12/633301   Filing Date: 08/Dec/2009

Abstract:

The present invention relates to a dissolvable article in the form of a porous dissolvable solid structure, comprising from about 10% to about 50% water soluble polymer

from about 1% to about 25% plasticizer

from about 23% to about 75% surfactant

wherein the surfactants comprise one or more surfactants from Group I, wherein Group I includes anionic surfactants, and one or more surfactants from Group II, wherein Group II includes a surfactant selected from the group consisting of amphoteric, zwitterionic and combinations thereof

wherein the ratio of Group I to Group II surfactants is from about 5:95 to about 30:70

and wherein the dissolvable article has a density of from about 0.05 g/cm3 to about 0.40 g/cm3.

Priority: US2008-120765P Applic. Date: 2008-12-08

Inventor: GLENN JR ROBERT WAYNE [US]; HEINRICH JAMES MERLE [US]; KAUFMAN KATHLEEN MARY [US]; TROKHAN DARREN PAUL [US]; DUFRESNE THOMAS EDWARD [US]; LUBBERS JULIE MASTERS [US]; BOLDEN RENEE DANIELLE [US]; SCHECHTMAN LEE ARNOLD [US]


Patent No.: US8470345B2  Issued: 25/Jun/2013

Title: Lipids containing omega-3 and omega-6 fatty acids

Applicant/Assignee: ENZYMOTEC LTD

Application No.: 12/590893   Filing Date: 16/Nov/2009

Abstract:

A lipid preparation including a glycerophospholipid or salt, conjugate and derivatives thereof, particularly phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidyl-inositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA), and poly-unsaturated fatty acid (PUFA) acyl groups, particularly long-chain poly-unsaturated fatty acid (LC-PUFA) acyl groups such as omega-3 and/or omega-6 acyl groups, wherein said PUFA is covalently bound to said glycerophospholipid. The preparation possesses an improved bioactivity, and is useful in the treatment of various cognitive and mental conditions and disorders and for maintenance of normal functions of brain-related systems and processes.

Priority: IL20030158552 Applic. Date: 2003-10-22; US2007-872258 Applic. Date: 2007-10-15; US2004-994175 Applic. Date: 2004-11-19; WO2004IL00957 Applic. Date: 2004-10-21

Inventor: BEN DROR GAI [IL]; PLATT DORIT [IL]; FARKASH ORLY [IL]; ZUABI RASSAN [IL]; BAR-ON ZOHAR [IL]; SHULMAN AVIDOR [IL]; PELLED DORI [IL]


Patent No.: US8470346B2  Issued: 25/Jun/2013

Title: ANTI-VIRAL PHARMACEUTICAL COMPOSITIONS

Applicant/Assignee: ADVENTRX PHARMACEUTICALS, INC, MAST THERAPEUTICS, INC

Application No.: 13/111873   Filing Date: 19/May/2011

Abstract:

The present invention provides antiviral compositions that comprise one or more of an ionic multivalent metal component, a cationic polymer, and a cationic surfactant. The present invention also provides methods for making and using such antiviral compositions.

Priority: US2004-003302 Applic. Date: 2004-12-03; US2003-528843P Applic. Date: 2003-12-10

Inventor: CHEN ANDREW XIAN [US]


Patent No.: US8481008B2  Issued: 09/Jul/2013

Title: PHOTOTHERAPY COMPOSITIONS AND METHODS

Applicant/Assignee: THERAKOS, INC

Application No.: 13/243103   Filing Date: 23/Sep/2011

Abstract:

Compositions containing a photoactivable agent and an agent that absorbs or blocks extraneous radiation during phototherapy are useful and used in methods to treat leukocyte mediated autoimmune diseases such as psoriasis, CTCL, and vertiligo.

Priority: US2005-311714 Applic. Date: 2005-12-19; US2004-638213P Applic. Date: 2004-12-22

Inventor: DECOLA DENNIS [US]; COLE CURTIS [US]


Patent No.: US8486374B2  Issued: 16/Jul/2013

Title: HYDROPHILIC, NON-AQUEOUS PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES

Applicant/Assignee: FOAMIX LTD

Application No.: 12/014088   Filing Date: 14/Jan/2008

Abstract:

A waterless composition suitable for delivery of an active agent to a body surface or cavity includes a vehicle having about 70% to about 99% by weight of a hydrophilic polar solvent, said hydrophilic solvent selected from the group consisting of (i) a mixture of two or more different polyethylene glycols (PEGs), wherein at least one PEG is a high molecular weight PEG having a melting point greater than 25 DEG C.

and (ii) propylene glycol (PG)

about 0% to about 10% of at least one surface active agent

about 0% to about 5% of a polymeric agent

about 0% to about 30% of a secondary hydrophilic solvent

and about 0% to about 5% of a silicone oil

and about 3% to about 25% hydrophobic propellant. The composition is otherwise substantially free of a hydrophobic solvent and includes at least one of a surface active agent and a polymeric agent.

The vehicle and the propellant are sufficiently miscible that the components may be homogeneously distributed with mild shaking.

Priority: US2006-430599 Applic. Date: 2006-05-09; US2004-835505 Applic. Date: 2004-04-28; US2007-947751 Applic. Date: 2007-11-29; US2007-653205 Applic. Date: 2007-01-12; US2004-911367 Applic. Date: 2004-08-04; US2007-880434P Applic. Date: 2007-01-12; US2007-919303P Applic. Date: 2007-03-21; US2005-679020P Applic. Date: 2005-05-09; US2003-530015P Applic. Date: 2003-12-16; US2003-492385P Applic. Date: 2003-08-04; US2006-861620P Applic. Date: 2006-11-29; US2006-784793P Applic. Date: 2006-03-21

Inventor: TAMARKIN DOV [IL]; EINI MEIR [IL]; FRIEDMAN DORON [IL]; BESONOV ALEX [IL]; SCHUZ DAVID [IL]; BERMAN TAL [IL]; DANZIGER JORGE [IL]; KEYNAN RITA [IL]; ZLATKIS ELLA [IL]


Patent No.: US8491920B2  Issued: 23/Jul/2013

Title: SKIN PROTECTION COMPOSITIONS, IN PARTICULAR CREAM TO PROTECT AGAINST COLD

Applicant/Assignee: EVONIK STOCKHAUSEN GMBH, EVONIK DEGUSSA GMBH

Application No.: 13/494351   Filing Date: 12/Jun/2012

Abstract:

The invention relates to a silicone-free skin protection composition, in particular a composition to protect against cold, containing the components a.) at least one oil with a pour point in accordance with DIN ISO 30 16 of @-10 DEG C., b.) at least one polyol c.) at least one emulsifier d.) optionally at least one wax, where the viscosity difference in the temperature interval from +4 DEG C. to +50 DEG C. of highest and lowest viscosity of the skin protection composition has a value in the range from 0 to @20 000 mPas.

Priority: DE20061053360 Applic. Date: 2006-11-10; US2009-514326 Applic. Date: 2009-05-11; WO2007EP09726 Applic. Date: 2007-11-09

Inventor: VEEGER MARCEL [DE]; ALLEF PETRA [DE]


Patent No.: US8492417B2  Issued: 23/Jul/2013

Title: TOPICAL USE OF THIAZOLIDINE DERIVATIVES AGAINST CONSEQUENCES OF OXIDATIVE STRESS OF SKIN

Applicant/Assignee: EXSYMOL S.A.M

Application No.: 13/708462   Filing Date: 07/Dec/2012

Abstract:

The invention concerns a cosmetic care method for opposing destructive effects of oxidative stress and its toxic by-products, comprising administering topically to a patient in need thereof, a derivative of formula (I): in which X is oxygen or sulphur. The invention especially applies to the domain of skin protection and more especially against cutaneous consequences of oxidative stress.

Priority: FR20070006641 Applic. Date: 2007-09-21; US2008-233661 Applic. Date: 2008-09-19

Inventor: SEGUIN MARIE CHRISTINE [MC]


Patent No.: US8492421B2  Issued: 23/Jul/2013

Title: AGENT FOR FUNGAL DERMATITIS

Applicant/Assignee: NIHON NOHYAKU CO., LTD

Application No.: 12/675441   Filing Date: 26/Aug/2008

Abstract:

The invention relates to a therapeutic agent for fungal dermatitis, containing luliconazole or a pharmaceutically acceptable salt thereof as an active ingredient, and a composition for the treatment of fungal dermatitis, containing luliconazole or lanoconazole in a substantially dissolved state as an active ingredient.

Priority: JP20070219333 Applic. Date: 2007-08-27; JP20070292284 Applic. Date: 2007-11-09; WO2008JP65186 Applic. Date: 2008-08-26

Inventor: KOGA HIROYASU [JP]; NANJOH YASUKO [JP]; KANEDA HIDEO [JP]


Patent No.: US8496944B2  Issued: 30/Jul/2013

Title: Process for the Manufacture of Powders of Inhalable Medicaments

Applicant/Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, BOEHRINGER INGELHEIM PHARMA GMBH CO. KG, INGELHEIM AM RHEIN, GERMANY AND ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

Application No.: 12/263818   Filing Date: 03/Nov/2008

Abstract:

The invention relates to an improved process for the production of powders of an inhalable medicament by crystallization from a supersaturated fluid containing said medicament, the method comprising passing along a tubular reactor (a) a segmented flow of that fluid comprised of discrete volumes

or (b) a fluid mixture being separated by discrete volumes of a separating fluid which is substantially immiscible with said fluid, characterized in that the crystallization is initiated by application of ultrasound.

Priority: EP20020023273 Applic. Date: 2002-10-17; US2003-685254 Applic. Date: 2003-10-14; US2002-425415P Applic. Date: 2002-11-12

Inventor: JONGEN NATHALIE [CH]; LEMAITRE JACQUES [CH]; BOWEN PAUL [CH]; DONNET MARCEL [CH]; SCHIEWE JOERG [DE]; ZIERENBERG BERND [DE]; SOARE CRISTINA LUCICA [CH]


Patent No.: US8506974B2  Issued: 13/Aug/2013

Title: SILICON-FREE HYDROCARBONS PROVIDING AESTHETIC VOLATILITY

Applicant/Assignee: PRESPERSE, INC, PRESPERSE CORPORATION

Application No.: 12/269608   Filing Date: 12/Nov/2008

Abstract:

Non-silicone-based compositions including hydrocarbons of widely different structures and origins are combined into single, stable, homogenous products with both aesthetic and volatility properties similar to a cyclopentasiloxane. The combinations are useful to cosmetic formulators as full or partial replacement products for cyclopentasiloxanes, or "volatile silicones."

Priority: US2007-987510P Applic. Date: 2007-11-13

Inventor: LABA DENNIS [US]; YEDNAK-CARPENTER MARIE [US]; SHAH PRITI [US]; COCHRAN STEVEN [US]


Patent No.: US8506975B2  Issued: 13/Aug/2013

Title: Cosmetic compositions utilizing a silicone-free hydrocarbon complex

Applicant/Assignee: PRESPERSE, INC, PRESPERSE CORPORATION

Application No.: 12/634036   Filing Date: 09/Dec/2009

Abstract:

Silicone-free compositions including hydrocarbons of widely different structures and origins combined with coated particles are provided which have both aesthetic and volatility properties similar to cyclopentasiloxane dispersions. The compositions are useful as full or partial replacement products for dispersions of cyclopentasiloxane, or "volatile silicones." The compositions are useful in UV-attenuating formulations including skin care products, color cosmetics, pharmaceutical products and especially sun care products such as sunblocks, sunscreens, tanning lotions, and the like.

Priority: US2008-121317P Applic. Date: 2008-12-10

Inventor: LABA DENNIS [US]; SHAH PRITI [US]; YEDNAK-CARPENTER MARIE [US]


Patent No.: US8507276B2  Issued: 13/Aug/2013

Title: Tissue culture media used as a component of cosmetics

Applicant/Assignee: JUVENA (INTERNATIONAL) AG,, LA PRAIRIE GROUP AG

Application No.: 11/285342   Filing Date: 23/Nov/2005

Abstract:

A cosmetic or dermatological preparation which comprises one or more tissue culture media, in particular one or more skin cell culture media.

Priority: DE2003123510 Applic. Date: 2003-05-24; DE2003155110 Applic. Date: 2003-11-24; DE20041020035 Applic. Date: 2004-04-22; WO2004EP05532 Applic. Date: 2004-05-22

Inventor: GOHLA SVEN [DE]; MOENKS MONIKA [CH]; IBANEZ SIBYLLE [CH]; EVANGELISTI CARMEN [CH]


Patent No.: US8518455B2  Issued: 27/Aug/2013

Title: Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Applicant/Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A

Application No.: 12/753368   Filing Date: 02/Apr/2010

Abstract:

A method for treating myocardial or skeletal muscle anoxia which occurs in coronary or post-infarct disorders or during prolonged physical activity and muscle fatigue. This method comprises the administration of a combination composition comprising (a) an alkanoyl L-carnitine selected from the group consisting of isovaleryl L-carnitine, propionyl L-carnitine or the pharmacologically acceptable salts thereof or mixtures thereof

and (b) ribose or a phosphate derivative thereof.

Priority: IT2000RM00323 Applic. Date: 2000-06-14; US2006-604390 Applic. Date: 2006-11-27; US2002-048590 Applic. Date: 2002-02-01; WO2001IT00283 Applic. Date: 2001-06-01

Inventor: PIETRO POLA [IT]


Patent No.: US8518991B2  Issued: 27/Aug/2013

Title: STRUCTURED COMPOSITIONS COMPRISING BETAINE

Applicant/Assignee: JOHNSON & JOHNSON CONSUMER COMPANIES, INC

Application No.: 11/770810   Filing Date: 29/Jun/2007

Abstract:

Provided are structured compositions comprising an anionic surfactant, a betaine, and a branched fatty alcohol, the composition having a Yield Stress from about 1 Pascal (Pa) to about 1500 Pa, as well as methods of making and using such compositions.

Priority:

Inventor: GUNN EUEN T [US]; NYSTRAND GLENN A [US]


Patent No.: US8524206B2  Issued: 03/Sep/2013

Title: AQUEOUS POLYAMINE-CONTAINING CARRIER SYSTEMS FOR WATER-INSOLUBLE MATERIALS

Applicant/Assignee: L'OREAL

Application No.: 13/396886   Filing Date: 15/Feb/2012

Abstract:

The present invention is drawn to a carrier composition containing: (a) at least one polyamine compound comprising at least two amino groups

(b) at least one nonionic surfactant

(c) at least one anionic silicone

and (d) at least one water-insoluble material, and wherein the composition, when combined with an aqueous phase, forms an aqueous delivery system which is both stable, and clear to slightly hazy/limpid in appearance.

Priority: US2005-154249 Applic. Date: 2005-06-16

Inventor: CANNELL DAVID W [US]; HASHIMOTO SAWA [US]; ESPINO CYNTHIA CHONG [US]; BARGER KATHERINE NATALIE [US]; NGUYEN NGHI VAN [US]


Patent No.: US8535693B2  Issued: 17/Sep/2013

Title: TOPICAL FORMULATION(S) FOR THE TREATMENT OF INFLAMMATION, SKIN AND MUCOSAL DISORDERS AND OTHER DISEASES THEREOF

Applicant/Assignee: LAILA PHARMACEUTICALS PVT. LTD, LAILA PHARMACEUTICALS PRIVATE LIMITED

Application No.: 13/132155   Filing Date: 01/Jun/2011

Abstract:

Nanoemulsified topical formulation comprising curcumin, tetrahydroxycurcumin (BDMC) and curcuminoid either alone or in combinations in an amount of 0.001% to 50% together with one or more pharmaceutically, nutraceutically or dietically acceptable excipient(s) or inactive ingredients, useful for the treatment of inflammation, various skin and oral disorders, mucosal disorders and other diseases associated or related thereof.

Priority: IN2008CH03007 Applic. Date: 2008-12-01; WO2009IN00689 Applic. Date: 2009-11-30

Inventor: CHANIYILPARAMPU RAMCHAND NANAPPAN [IN]; MUNGALA MADHAVI [IN]; KAPOOR ANUJ [IN]; GOKARAJU GANGA RAJU [IN]; GOKARAJU RAMA RAJU [IN]; BHUPATHIRAJU KIRAN [IN]; GOLAKOTI TRIMURTULU [IN]; NAIR ANITHA KRISHNAN [IN]; MURALI MALLIGA RAMAN [IN]; PARTHASARATHY KAVITHA [IN]


Patent No.: US8557260B2  Issued: 15/Oct/2013

Title: COMPOSITION COMPRISING AT LEAST TWO DIFFERENT CYCLOALKYLMETHICONES AND USE THEREOF

Applicant/Assignee: MOMENTIVE PERFORMANCE MATERIALS INC

Application No.: 12/640235   Filing Date: 17/Dec/2009

Abstract:

A cosmetic composition includes comprising a blend of cycloalkylmethicones comprising at least two different cycloalkylmethicones having general formula I: where R1 is a hydrocarbon radical containing about 2 to about 4 carbon atoms

R2, R3, R4, R5, and R6 are independently selected from the group consisting of a hydrocarbon radical containing about 1 to about 4 carbon atoms

a is a positive number between 0

b and c are independently selected from 0 to 5 wherein (a+b+c)@5

and wherein the rates of evaporation of the composition as measured in accordance with standard DIN 53249 test is from about 80% to about 99% by weight loss in about 200 to about 6000 minutes, more preferably in about 200 to about 1000 minutes, and even more preferably in about 200 to about 500 minutes.

Priority: US2008-203082P Applic. Date: 2008-12-18

Inventor: FALK BENJAMIN [US]


Patent No.: US8557269B2  Issued: 15/Oct/2013

Title: Paper tissue with high lotion transferability

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 11/105996   Filing Date: 14/Apr/2005

Abstract:

A paper tissue and products made from paper tissue, such as paper handkerchiefs, facial tissues, bath and cosmetic tissues, paper tissue wipes of any kinds and the like. The invention describes both the process for making a smooth and absorbent lotioned paper tissue, with high transferability of the lotion. The process steps comprises the steps of (a) providing a paper tissue web continuously moving next to a lotion application unit comprising at least one rotating surface, (b) transferring said lotion onto one rotating surface,'(c) expulsing said lotion from the said rotating surface into a stream of lotion droplets, by primarily the centrifugal force of the rotation of said rotating surface, (d) intercepting said paper tissue with said stream of lotion droplets. The invention also describes a paper tissue comprising a lotion distributed as discrete deposits on its surface.

The deposits have a high local concentration of lotion and cover a relatively small area of the tissue.

Priority: US2004-565105P Applic. Date: 2004-04-23

Inventor: KLEINWAECHTER JOERG [DE]; BUTZ DIRK [DE]; MARCOTT CURTIS ALLEN [US]; DI GIROLAMO LUIGI [IT]


Patent No.: US8562962B2  Issued: 22/Oct/2013

Title: Treatment and Composition for Achieving Skin Anti-Aging Benefits by Corneum Protease Activation

Applicant/Assignee: MARY KAY, INC, MARY KAY INC

Application No.: 13/619677   Filing Date: 14/Sep/2012

Abstract:

Disclosed is a topical skin composition, and methods for its use, comprising a chemically compatible combination of one or more surfactants and at least one chelating agent, an algae extract, and magnesium ascorbyl phosphate, wherein the composition is formulated for topical application to skin.

Priority: US2009-632554 Applic. Date: 2009-12-07; US2008-202924 Applic. Date: 2008-09-02; US2007-624840 Applic. Date: 2007-01-19; US2002-273649 Applic. Date: 2002-12-12; US1999-357288 Applic. Date: 1999-07-20

Inventor: SCHILTZ JOHN R [US]


Patent No.: US8563072B2  Issued: 22/Oct/2013

Title: Suspension containing hydronium stabilized colloidal silicic acid nanoparticles, formulation obtained from the said diluted suspension, powder obtained from the said de-hydrated suspension, compositions obtained from the said powder, preparation and use

Applicant/Assignee: AQUARIUS INVESTHOLDING, SARL, JISBREY, S.A

Application No.: 12/988183   Filing Date: 16/Apr/2009

Abstract:

The present invention relates to hydronium stabilized silicic acid nanoparticles, to the formulation obtained from the said diluted suspension, to the powder obtained from the said dehydrated suspension and to the preparation or dosage form obtained from the said suspension, formulation or powder, to their preparation and their use in all kinds of applications in the domains of food, medicine, pharmaceutics, cosmetics. The present invention provides a stable suspension of colloidal silicic acid nanoparticles having a pH lower than 0.9, a molar silicon concentration between 0.035 and 0.65, a free water concentration of at least 30% (w/v) and a ratio between hydronium ion and Si molar concentrations higher than 2 and preferably inferior to 4.

The present invention further provides a method for preparing a stable suspension of colloidal silicic acid nanoparticles, which comprises the steps of providing an aqueous inorganic or organic silicon solution and quick mixing said aqueous inorganic or organic silicon solution with water containing a strong acidic compound at a temperature inferior at 30 DEG C., preferably comprised between 1 and 25 DEG C., to form a suspension of colloidal silicic acid nanoparticles having a pH lower than 0.9, stabilized by hydronium ions, the ratio between hydronium ions and Si molar concentrations being higher than 2 and preferably inferior to 4, for a molar silicon concentration between 0.035 and 0.65 and a free water concentration of at least 30% (w/v).

Priority: WO2008EP54643 Applic. Date: 2008-04-17; WO2009EP54515 Applic. Date: 2009-04-16

Inventor: SUVEE IVO [PE]; TOURGIS GUILLAUME [FR]


Patent No.: US8568704B2  Issued: 29/Oct/2013

Title: Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer

Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT, BIOT, FRANCE, GALDERMA RESEARCH & DEVELOPMENT

Application No.: 12/453968   Filing Date: 28/May/2009

Abstract:

Topically applicable, dermatological/pharmaceutical compositions contain, formulated into a physiologically acceptable medium, benzoyl peroxide, at least one naphthoic acid compound and at least one compound of the polyurethane polymer type or derivatives thereof, wherein the benzoyl peroxide and the at least one naphthoic acid compound are dispersed therein.

Priority: FR20060055138 Applic. Date: 2006-11-28; WO2007FR52412 Applic. Date: 2007-11-28

Inventor: MALLARD CLAIRE [FR]; AT EMMANUELLE [FR]


Patent No.: US8568752B2  Issued: 29/Oct/2013

Title: TREATMENT AND COMPOSITION FOR ACHIEVING SKIN ANTI-AGING BENEFITS BY CORNEUM PROTEASE ACTIVATION

Applicant/Assignee: MARY KAY, INC, MARY KAY INC

Application No.: 13/852542   Filing Date: 28/Mar/2013

Abstract:

Disclosed is a method of brightening skin or evening out the tone of skin comprising topically applying to skin in need thereof a composition comprising a chemically compatible combination of one or more surfactants and at least one chelating agent, ascorbic acid or a derivative thereof, algae extract, and kelp or sodium sulfite and sodium metabisulfite.

Priority: US201213619677 Applic. Date: 2012-09-14; US2009-632554 Applic. Date: 2009-12-07; US2008-202924 Applic. Date: 2008-09-02; US2007-624840 Applic. Date: 2007-01-19; US2002-273649 Applic. Date: 2002-12-12; US1999-357288 Applic. Date: 1999-07-20

Inventor: SCHULTZ JOHN R [US]


Patent No.: US8586621B2  Issued: 19/Nov/2013

Title: ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES

Applicant/Assignee:

Application No.: 12/447307   Filing Date: 26/Oct/2007

Abstract:

The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic interaction of Diindolylmethane-related indoles with other known anti-parasitic and pro-apoptotic agents is believed to permit more effective therapy and prevention of protozoal parasitic infections. The methods and compositions described provide new treatment of protozoal parasitic diseases of mammals and birds including malaria, leishmaniasis, trypanosomiasis, trichomoniasis, neosporosis and coccidiosis.

Priority: US2006-854830P Applic. Date: 2006-10-27; WO2007US22649 Applic. Date: 2007-10-26

Inventor: ZELIGS MICHAEL A [US]


Patent No.: US8591938B2  Issued: 26/Nov/2013

Title: Liquid compositions of calcium acetate

Applicant/Assignee: LYNE LABORATORIES, LYNE LABORATORIES, INC

Application No.: 11/878169   Filing Date: 20/Jul/2007

Abstract:

The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of an individual by administering to the individual an aqueous solution of at least calcium acetate.

Priority: US2006-832093P Applic. Date: 2006-07-21

Inventor: TARALLO STEPHEN C [US]


Patent No.: US8592480B2  Issued: 26/Nov/2013

Title: LIQUID COMPOSITIONS OF CALCIUM ACETATE

Applicant/Assignee: LYNE LABORATORIES, LYNE LABORATORIES, INC

Application No.: 13/162938   Filing Date: 17/Jun/2011

Abstract:

The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of an individual by administering to the individual an aqueous solution of at least calcium acetate.

Priority: US2007-878169 Applic. Date: 2007-07-20; US2006-832093P Applic. Date: 2006-07-21

Inventor: TARALLO STEPHEN C [US]


Patent No.: US8597622B2  Issued: 03/Dec/2013

Title: Deodorant cosmetic composition comprising a combination of a lipophilic salicylic acid derivative and an antiperspirant aluminium salt

Applicant/Assignee: L'OREAL

Application No.: 11/918741   Filing Date: 15/Mar/2006

Abstract:

The present invention relates to a deodorant cosmetic composition comprising: (a) at least one lipophilic salicylic acid derivative of formula (I) below, or a salt thereof: (b) at least one antiperspirant aluminum salt

in an (a)/(b) weight ratio of less than 1/20. The invention also relates to a cosmetic process for treating human perspiration and human body odor, in particular underarm perspiration and underarm odor, using this composition. The invention relates to the use of a combination of at least (a) one lipophilic salicylic acid derivative of formula (I), or a salt thereof, and of at least (b) one antiperspirant aluminum salt, in an (a)/(b) weight ratio of less than 1/20, as a deodorant active agent in a cosmetic composition.

Priority: FR20050050993 Applic. Date: 2005-04-19; US2005-675868P Applic. Date: 2005-04-29; WO2006EP03303 Applic. Date: 2006-03-15

Inventor: LEMOINE CYRIL [FR]; LEBON-HIPOLITE EMMANUELLE [FR]


Patent No.: US8597642B2  Issued: 03/Dec/2013

Title: TABLETTABLE FORMULATIONS OF LIPOPHILIC HEALTH INGREDIENTS

Applicant/Assignee: DSM IP ASSETS B.V

Application No.: 12/669057   Filing Date: 21/Jul/2008

Abstract:

The present invention is directed to a formulation of a lipophilic health ingredient comprising a lipophilic health ingredient, a protective colloid comprising a modified starch and an emulsifier. The present invention is further directed to a formulation of (a) lipophilic health ingredient(s) comprising (a) lipophilic health ingredient(s) and a protective colloid, wherein said protective colloid is a modified starch, characterized in that the formulation has a residual moisture content @6.5 weight-%, based on the total weight of the formulation, as well as to a process for their manufacture. The latter formulations are especially suitable for the preparation of stable tablets of these lipophilic health ingredients.

Priority: US2007-929945P Applic. Date: 2007-07-19; WO2008EP05945 Applic. Date: 2008-07-21

Inventor: DIGUET SYLVAIN [FR]; LEUENBERGER BRUNO H [CH]; SCHLEGEL BERND [DE]; ULM JOHANN [CH]


Patent No.: US8603498B2  Issued: 10/Dec/2013

Title: Lipo-Phosphated or Lipo-Sulphated Compound, Compositions Comprising It and Topical Uses Thereof

Applicant/Assignee: SEDERMA, S.A.S

Application No.: 13/522663   Filing Date: 17/Jan/2011

Abstract:

The compound according to the invention has the following developed formula IX: wherein: X=PO(OH)2

SO2(OH)

PO(OH)(Xaa)m or SO2(Xaa)m

A=H

OH

NH2 or akyl (1-6C)

n=1 to 4

Y=-CO-OR2

-CO-NR3R4

-O-CO-R2

-C=CR2

R2=an alkyl, aryl, aralkyl, acyl, sulfonyl, sugar or alkoxy chain of 1 to 24 carbon atoms, linear, branched or cyclic, with or without substitutions, saturated or not, hydroxylated or not, sulfurated or not

R5=OH, O-alk (1-6C), (Xaa)m, NH2 or NH-alkyl(1-6C)

Xaa=peptide of m aminoacids Xaa with m from 1 to 10

The compound is preferably phosphated, obtained from malic acid and having the following developed formula: A cosmetic composition comprising the compound of the present invention can improve the general condition of the skin, for example hydration, lightening and mechanical properties.

Priority: FR20100050306 Applic. Date: 2010-01-18; WO2011IB50196 Applic. Date: 2011-01-17

Inventor: FOURNIAL ARNAUD [FR]; MONDON PHILIPPE [FR]; PESCHARD OLIVIER [FR]


Patent No.: US8603503B2  Issued: 10/Dec/2013

Title: Biliquid foams stable dispersions thereof and a corresponding process of manufacturing

Applicant/Assignee: DRUG DELIVERY SOLUTIONS LIMITED

Application No.: 10/566210   Filing Date: 30/Jul/2004

Abstract:

A biliquid foam includes from 10% to 98% by weight of a non-polar liquid other than a fuel and from 2 to 88% by weight of a continuous phase polar liquid comprising a C1-C4 alcohol, a liquid polyethylene glycol, ethylene glycol or propylene glycol, or mixtures thereof, in an amount of at least 65% by weight, relative to the weight of the continuous phase, wherein the biliquid foam is stabilized with an amount of from 0.05% to 2% by weight based on the total formulation of a surfactant which is selected from castor oil/poly(alkylene glycol) adducts containing from 20 to 50 alkoxy groups, a C8-C24 fatty acid or hydrogenated castor oil/poly(alkylene glycol) adducts containing from 20 to 60 alkoxy groups, or mixtures thereof.

Priority: GB20030017868 Applic. Date: 2003-07-30; WO2004GB03318 Applic. Date: 2004-07-30

Inventor: DIAS MONICA [GB]; GUFFOGG PHILIP [GB]; WHEELER DEREK [GB]; WHITBREAD-JORDAN MARK [GB]


Patent No.: US8609077B2  Issued: 17/Dec/2013

Title: Polysiloxane compositions

Applicant/Assignee: BASF SE

Application No.: 10/508441   Filing Date: 13/Mar/2003

Abstract:

Compositions containing polyorganosiloxanes having at least one quaternary group comprising at least one nitrogen atom, and at least one further polar radical, and their use in cosmetic, in particular for the conditioning of hair.

Priority: US2002-366311P Applic. Date: 2002-03-21; WO2003EP02617 Applic. Date: 2003-03-13

Inventor: ELDER STEWART TODD [US]; ROCAFORT COLLEEN [US]; SCHWENKER CLAIRE A [US]; CHROBACZEK HARALD [DE]


Patent No.: US8609147B2  Issued: 17/Dec/2013

Title: Use of deuterium oxide for treatment of herpes virus-based diseases of the skin

Applicant/Assignee: D2 BIOSCIENCE GROUP LTD

Application No.: 12/168583   Filing Date: 07/Jul/2008

Abstract:

The present invention relates to the use of deuterium oxide (D2O) for prevention and/or treatment of virus-based diseases of the skin, in particular herpes virus-based and verrucal virus-based diseases of the skin.

Priority: DE20071031397 Applic. Date: 2007-07-05

Inventor: BAYERL THOMAS M [GB]


Patent No.: US8609722B2  Issued: 17/Dec/2013

Title: Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine

Applicant/Assignee:

Application No.: 10/562392   Filing Date: 01/Jun/2004

Abstract:

Compositions having a mixture of lidocaine, prilocaine and tetracaine, or their pharmaceutically acceptable salts. A preferred composition includes the following components in the indicated approximate w/w percentages: 1.5% lidocaine base

1.5% prilocaine base

4% tetracaine base and water. In some implementations, also included may be about 10% methylpynrolidone

2% dimethyl sulfoxide

0.08% topical hyaluronidase

1.5% guar gum

1% polyoxyethylenesorbitan monolaurate

0.5 polyoxyethylenesorbitan monooleate, and water to 100%. Such compositions exhibits a high concentration on skin, a deep anesthetic effect and a significantly more rapid onset of the anesthetic effect than comparable transdermal anesthetics.

Priority: ES20030001548 Applic. Date: 2003-06-19; WO2004EP50967 Applic. Date: 2004-06-01

Inventor: FITA FERNANDO BOUFFARD [ES]


Patent No.: US8613956B2  Issued: 24/Dec/2013

Title: COSMETIC PARTICLES THAT TRANSFORM FROM HARD TO SOFT PARTICLES COMPRISING HYDROGENATED LONG-CHAIN TRIGLYCERIDE OILS

Applicant/Assignee: INTERNATIONAL FLORA TECHNOLOGIES LTD, INTERNATIONAL FLORA TECHNOLOGIES, LTD

Application No.: 12/488205   Filing Date: 19/Jun/2009

Abstract:

Cosmetic particle compositions are provided which are adapted to form hard cosmetic particles that transform to soft cosmetic particles after their incorporation into topical formulations, particularly surfactant-based topical formulations. The composition includes one or more partially or fully hydrogenated triglyceride oils, at least 50% of which have at least 15% by weight fatty acid moieties with carbon chain lengths of C18 or higher. Additives may be disposed in or on the hard cosmetic particles and delivered when the cosmetic particles are broken proximate a target such as the skin, hair or nails of a mammalian subject or another target. The transformable hard cosmetic particles permit the storage and shipment of intact cosmetic particles yet transform in situ to achieve the benefits of soft cosmetic particles.

Priority: US2008-074872P Applic. Date: 2008-06-23

Inventor: KLEIMAN ROBERT [US]; BROWN JAMES H [US]; DWYER KELLEY [US]; BROWN JAMES S [US]


Patent No.: US8617576B2  Issued: 31/Dec/2013

Title: PRESERVATION OF BIOACTIVE MATERIALS BY FREEZE DRIED FOAM

Applicant/Assignee: MEDIMMUNE, LLC

Application No.: 12/451454   Filing Date: 06/May/2008

Abstract:

This invention provides methods, systems and compositions to preserve bioactive materials in a dried foam matrix. Methods provide non-boiling foam generation and penetration of preservative agents at temperatures near the phase transition temperature of the membranes. Bioactive materials can be preserved with high initial viability in a freeze-foam process employing low temperature secondary drying.

Priority: US2007-930746P Applic. Date: 2007-05-18; WO2008US05840 Applic. Date: 2008-05-06

Inventor: VEHRING REINHARD [US]; AO YI [US]

Clck to enlarge and view details
   
US Patents Granted in 2012
...or use our Search Engine to
search for patent documents by
number.
Search for anything. Simply
type the words in the box..